Report Detail

Other Global Cancer Diagnostics Device Market Insights, Forecast to 2025

  • RnM3515183
  • |
  • 11 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.
The Americas dominated the global cancer diagnostic devices market in 2015 with a market share of close to 53% and will retain its leadership position until the end of 2020. The Americas region has several well-known medical facilities, which focus on targeted therapeutic methods to treat different types of cancers. The availability of a large number of medical facilities in the Americas will lead to the strong growth of this market over the forecast period.
The global Cancer Diagnostics Device market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Diagnostics Device market based on company, product type, end user and key regions.

This report studies the global market size of Cancer Diagnostics Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Diagnostics Device in these regions.
This research report categorizes the global Cancer Diagnostics Device market by top players/brands, region, type and end user. This report also studies the global Cancer Diagnostics Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics

Market size by Product
Companion Diagnostics
Molecular Diagnostics
Market size by End User
Lung
Breast
Colorectal
Prostate
Cervical
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Cancer Diagnostics Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Diagnostics Device market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Diagnostics Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Diagnostics Device submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cancer Diagnostics Device are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Diagnostics Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Cancer Diagnostics Device Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cancer Diagnostics Device Market Size Growth Rate by Product
      • 1.4.2 Companion Diagnostics
      • 1.4.3 Molecular Diagnostics
    • 1.5 Market by End User
      • 1.5.1 Global Cancer Diagnostics Device Market Size Growth Rate by End User
      • 1.5.2 Lung
      • 1.5.3 Breast
      • 1.5.4 Colorectal
      • 1.5.5 Prostate
      • 1.5.6 Cervical
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cancer Diagnostics Device Market Size
      • 2.1.1 Global Cancer Diagnostics Device Revenue 2014-2025
      • 2.1.2 Global Cancer Diagnostics Device Sales 2014-2025
    • 2.2 Cancer Diagnostics Device Growth Rate by Regions
      • 2.2.1 Global Cancer Diagnostics Device Sales by Regions
      • 2.2.2 Global Cancer Diagnostics Device Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cancer Diagnostics Device Sales by Manufacturers
      • 3.1.1 Cancer Diagnostics Device Sales by Manufacturers
      • 3.1.2 Cancer Diagnostics Device Sales Market Share by Manufacturers
      • 3.1.3 Global Cancer Diagnostics Device Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Diagnostics Device Revenue by Manufacturers
      • 3.2.1 Cancer Diagnostics Device Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cancer Diagnostics Device Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cancer Diagnostics Device Price by Manufacturers
    • 3.4 Cancer Diagnostics Device Manufacturing Base Distribution, Product Types
      • 3.4.1 Cancer Diagnostics Device Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cancer Diagnostics Device Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cancer Diagnostics Device Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cancer Diagnostics Device Sales by Product
    • 4.2 Global Cancer Diagnostics Device Revenue by Product
    • 4.3 Cancer Diagnostics Device Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cancer Diagnostics Device Breakdown Data by End User

    6 North America

    • 6.1 North America Cancer Diagnostics Device by Countries
      • 6.1.1 North America Cancer Diagnostics Device Sales by Countries
      • 6.1.2 North America Cancer Diagnostics Device Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cancer Diagnostics Device by Product
    • 6.3 North America Cancer Diagnostics Device by End User

    7 Europe

    • 7.1 Europe Cancer Diagnostics Device by Countries
      • 7.1.1 Europe Cancer Diagnostics Device Sales by Countries
      • 7.1.2 Europe Cancer Diagnostics Device Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cancer Diagnostics Device by Product
    • 7.3 Europe Cancer Diagnostics Device by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cancer Diagnostics Device by Countries
      • 8.1.1 Asia Pacific Cancer Diagnostics Device Sales by Countries
      • 8.1.2 Asia Pacific Cancer Diagnostics Device Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cancer Diagnostics Device by Product
    • 8.3 Asia Pacific Cancer Diagnostics Device by End User

    9 Central & South America

    • 9.1 Central & South America Cancer Diagnostics Device by Countries
      • 9.1.1 Central & South America Cancer Diagnostics Device Sales by Countries
      • 9.1.2 Central & South America Cancer Diagnostics Device Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cancer Diagnostics Device by Product
    • 9.3 Central & South America Cancer Diagnostics Device by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cancer Diagnostics Device by Countries
      • 10.1.1 Middle East and Africa Cancer Diagnostics Device Sales by Countries
      • 10.1.2 Middle East and Africa Cancer Diagnostics Device Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cancer Diagnostics Device by Product
    • 10.3 Middle East and Africa Cancer Diagnostics Device by End User

    11 Company Profiles

    • 11.1 Abbott Diagnostics
      • 11.1.1 Abbott Diagnostics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Diagnostics Cancer Diagnostics Device Products Offered
      • 11.1.5 Abbott Diagnostics Recent Development
    • 11.2 Agilent Technologies
      • 11.2.1 Agilent Technologies Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Agilent Technologies Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Agilent Technologies Cancer Diagnostics Device Products Offered
      • 11.2.5 Agilent Technologies Recent Development
    • 11.3 BD
      • 11.3.1 BD Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BD Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BD Cancer Diagnostics Device Products Offered
      • 11.3.5 BD Recent Development
    • 11.4 bioMérieux
      • 11.4.1 bioMérieux Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 bioMérieux Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 bioMérieux Cancer Diagnostics Device Products Offered
      • 11.4.5 bioMérieux Recent Development
    • 11.5 Qiagen
      • 11.5.1 Qiagen Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Qiagen Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Qiagen Cancer Diagnostics Device Products Offered
      • 11.5.5 Qiagen Recent Development
    • 11.6 Roche Diagnostics
      • 11.6.1 Roche Diagnostics Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Roche Diagnostics Cancer Diagnostics Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Roche Diagnostics Cancer Diagnostics Device Products Offered
      • 11.6.5 Roche Diagnostics Recent Development

    12 Future Forecast

    • 12.1 Cancer Diagnostics Device Market Forecast by Regions
      • 12.1.1 Global Cancer Diagnostics Device Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cancer Diagnostics Device Revenue Forecast by Regions 2019-2025
    • 12.2 Cancer Diagnostics Device Market Forecast by Product
      • 12.2.1 Global Cancer Diagnostics Device Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cancer Diagnostics Device Revenue Forecast by Product 2019-2025
    • 12.3 Cancer Diagnostics Device Market Forecast by End User
    • 12.4 North America Cancer Diagnostics Device Forecast
    • 12.5 Europe Cancer Diagnostics Device Forecast
    • 12.6 Asia Pacific Cancer Diagnostics Device Forecast
    • 12.7 Central & South America Cancer Diagnostics Device Forecast
    • 12.8 Middle East and Africa Cancer Diagnostics Device Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cancer Diagnostics Device Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Cancer Diagnostics Device . Industry analysis & Market Report on Cancer Diagnostics Device is a syndicated market report, published as Global Cancer Diagnostics Device Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cancer Diagnostics Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,900.40
      5,850.60
      7,800.80
      4,552.10
      6,828.15
      9,104.20
      754,306.00
      1,131,459.00
      1,508,612.00
      409,199.00
      613,798.50
      818,398.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report